serena williams weight loss glp 1 Opens Up About Using GLP-1 In Her Journey Serena Williams' GLP-1 Shift: 34

Together with Ryan Livingston, we created a piece looking back at the 1-year implications of the GLP-1 antagonist for CKD and T2D, speaking with key experts from Cleveland Clinic and the American Heart Association, along with Holly Kramer from Loyola Medicine, Editor-in-Chief at Advances in Kidney Disease and Health (AKDH)

At Sanctuary Wellness, were here to hold space for that conversation

The wide range of health benefits associated with weight loss among obese individuals has led researchers to investigate different mechanisms and identify pharmacological targets to treat obesity

FDA (2008)

Chippewa Valley Technical College

The PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and evaluates key variants including GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313genetic sites that influence how effectively someone's body responds to GLP-1 activation